ClinVar Miner

Submissions for variant NM_000083.3(CLCN1):c.1592C>T (p.Ala531Val)

gnomAD frequency: 0.00001  dbSNP: rs80356704
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000638249 SCV000759735 pathogenic Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form 2024-01-18 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 531 of the CLCN1 protein (p.Ala531Val). This variant is present in population databases (rs80356704, gnomAD 0.04%). This missense change has been observed in individual(s) with myotonia congenita (PMID: 10430417, 11840191, 21221019, 22094069, 23933576; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 21040). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CLCN1 function (PMID: 17990293, 23424641, 23933576, 26021757, 27580824). For these reasons, this variant has been classified as Pathogenic.
Athena Diagnostics RCV000711222 SCV000841554 pathogenic not provided 2018-04-24 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV000711222 SCV001715973 pathogenic not provided 2019-07-07 criteria provided, single submitter clinical testing PS3, PS4_moderate, PM3, PP1, PP3
Fulgent Genetics, Fulgent Genetics RCV000638249 SCV002811023 pathogenic Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form 2022-04-28 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002267607 SCV004020372 pathogenic Congenital myotonia, autosomal recessive form 2023-06-23 criteria provided, single submitter clinical testing Variant summary: CLCN1 c.1592C>T (p.Ala531Val) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 251370 control chromosomes, exclusively at a frequency of 4.4e-05 (i.e., 11 heterozygotes) within the Finnish subpopulation in the gnomAD database. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1592C>T has been reported in the literature in multiple compound heterozygous individuals affected with Congenital Myotonia, Autosomal Recessive Form (e.g., Sun_2002, Modoni_2011). Additionally, the variant was identified in several apparent heterozygotes affected with myotonia and latent myotonia, but was observed in unaffected heterozygous carriers as well, suggesting this variant may also cause autosomal dominant disease although with reduced penetrance (e.g., Sun_2002). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 21221019, 11840191). Five submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Laboratory of Medical Genetics, National & Kapodistrian University of Athens RCV002267607 SCV004697554 pathogenic Congenital myotonia, autosomal recessive form 2024-02-20 criteria provided, single submitter clinical testing
GeneReviews RCV000020102 SCV000040422 not provided Batten-Turner congenital myopathy no assertion provided literature only Associated with autosomal recessive and autosomal dominant mode of inheritance
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences RCV002267607 SCV002549783 pathogenic Congenital myotonia, autosomal recessive form 2022-04-06 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.